Dr. Martens commands a high Ebitda multiple with its IPO

2021-01-27T10:04:00

Dr. Martens logo

Dr. Martens is being valued between £3.3-3.7 billion (€3.7bn-$4.5bn to €4.2bn-$5.1bn) in its planned public offering on the London Stock Exchange, whichis already fully booked. The valuation implies a multiple of over 17 times Ebitda, as the company generated Ebitda of £184 million (€204.2m-$248.3m) on revenues of £672 million (€745.8m-$907m) ...

You’ve read your 2 free articles this month

Register  a free account or login  to unlock 3 more articles each week

SIGN-IN if you are already a subscriber of SGI Europe.

Gated access promo

Register today and unlock 3 more articles each week

See what industry leaders read every day:

  • Curated industry intelligence  you won’t find anywhere else—selected from 500+ sources
  • Exclusive interviews, case studies, and consumer insights  on emerging markets and trends
  • Expert analysis  on corporate moves, financials, retail trends, regulation, and innovation
  • The Daily Digest —essential sporting goods news delivered every morning

Register for free

Already a subscriber? Sign in

Ready for unlimited coverage?

Upgrade to Professional or Premium for unlimited access to exclusive reports,
C-suite interviews, market analysis, and industry-wide research—with team licensing included.

Compare subscription plans

Already registered? Sign in here